The potential of integrating stereotactic ablative radiotherapy techniques with hyperfractionation for lung cancer.
Chi-Chuan ChiouYuan-Hung WuPin-I HuangKeng-Li LanYi-Wei ChenYu-Mei KangLin-Shan ChouYu-Wen HuPublished in: Thoracic cancer (2024)
The hyperfractionated regimen has an advantage in the high-dose region of the lung but a disadvantage in the low-dose region. Further research is needed to determine the superiority between hypo- and hyperfractionation.